Core Viewpoint - The stock of United Imaging Healthcare (688271) has shown a slight increase of 0.15% as of November 27, 2025, with significant fluctuations in capital flow indicating mixed investor sentiment [1][2]. Financial Performance - For the first three quarters of 2025, United Imaging Healthcare reported a main business revenue of 8.859 billion yuan, a year-on-year increase of 27.39% [3]. - The net profit attributable to shareholders reached 1.12 billion yuan, up 66.91% year-on-year, while the non-recurring net profit was 1.053 billion yuan, reflecting a substantial increase of 126.94% [3]. - In Q3 2025 alone, the company achieved a main business revenue of 2.843 billion yuan, a remarkable year-on-year growth of 75.41% [3]. Market Position - United Imaging Healthcare's total market capitalization stands at 108.871 billion yuan, ranking 2nd in the medical device industry [3]. - The company has a net asset value of 20.805 billion yuan, placing it 3rd in the industry [3]. - The company's net profit margin is 12.44%, which is higher than the industry average of 9.57%, ranking 56th out of 124 companies [3]. Stock Performance and Investor Sentiment - As of November 27, 2025, the stock's turnover rate was 0.42%, with a trading volume of 34,900 hands and a transaction value of 460 million yuan [1]. - Over the past five days, the stock has experienced varying capital flows, with a net outflow of 3.4216 million yuan from main funds on November 27, 2025 [2]. - The average target price set by 27 institutions over the last 90 days is 175.6 yuan, with 20 institutions giving a buy rating and 7 an increase rating [4].
股票行情快报:联影医疗(688271)11月27日主力资金净卖出342.16万元